Aging Journal News
ABOUT Dr. Mikhail (Misha) Blagosklonny:
It is with great sadness and heavy heart that we announce the recent passing of Dr. Mikhail (Misha) V. Blagosklonny, our beloved Editor-in-Chief. Misha succumbed to metastatic lung cancer after a courageous battle.
Dr. Blagosklonny will be remembered as a brilliant and extraordinary scientist who dedicated his life to science. He was a visionary thinker, who made highly original contributions to cancer and aging research that were often ahead of their time.
Dr. Blagosklonny was born into a family of scientists. His mother, Professor of Medicine Yanina V. Blagosklonnaya, specialized in endocrinology and was a talented teacher, mentoring several generations of medical students. His father, Professor Vladimir M. Dilman, was a brilliant gerontologist, endocrinologist and oncologist, known for being a very charismatic person. He was the first person to encourage Misha to think about nature, aging, and philosophy.
Misha was a theorist by nature. While in school, he was deeply interested in physics and dreamed of becoming a theoretical physicist. Eventually, he chose biology, driven to study aging and age-related diseases, including cancer. He started as an experimentalist, but over the years, he became a theoretical biologist. In a way, his dream came true.
In Remembrance | Call for Papers: Commemorative Collection Honoring Dr. Blagosklonny | @Blagosklonny
ABOUT MishaBlagosklonny.com:
Read the latest news about recent and trending scientific papers published by Aging—a rigorously peer-reviewed open-access scientific journal.
The mission of the journal is to serve as a platform for high-quality research that uncovers the cellular, molecular, and systemic processes underlying aging, and translates these insights into strategies to extend healthspan and delay the onset of chronic disease.
We aim to promote: 1) The development of preventative strategies that delay or mitigate age-associated pathologies by modulating key aging mechanisms, 2) the treatment of age-related diseases through interventions that target the aging process itself, and 3) the validation of anti-aging therapies by demonstrating their impact on functional decline and disease onset.
Impact Journals (Aging‘s publishers) meets the standards of the Wellcome Trust Publisher Requirements and was included into the Wellcome Trust List of Compliant Publishers. Read about our rigorous Scientific Integrity Process.
To learn more, please visit Aging-us.com or follow @AgingJrnl on X and @AgingUS on Facebook.
